Minnesota tax credit to benefit early-stage companies
This article was originally published in The Gray Sheet
Executive Summary
Minnesota companies and investors will be able to apply for a new 25% angel investor tax credit by late summer. Gov. Tim Pawlenty signed the credit into law on April 1, implementing a policy that industry trade group LifeScience Alley said is designed to improve access to early-stage funding. Minnesota and out-of-state investors are eligible. Qualifying companies must have received less than $2 million in private equity, have fewer than 25 employees and be less than 10 years old
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
England’s NICE Says No To Santhera’s DMD Drug Agamree Due To ‘Unreliable Modeling’
Santhera Pharmaceuticals did not provide enough evidence to demonstrate that its Duchenne muscular dystrophy drug Agamree was a cost-effective use of resources, according to draft guidance from England’s health technology assessment body, NICE.
Timely Acquisition Keeps Germany's Dermapharm Growing
With its Branded Pharmaceuticals division negatively impacted by the end of the COVID-19 pandemic, the timely acquisition of supplements firm Arkopharma ensured Dermapharm recorded double-digit sales growth in 2023.